Quote | Skye Bioscience Inc Com (OTCMKTS:SKYE)
Last: | $14.81 |
---|---|
Change Percent: | -5.81% |
Open: | $15.67 |
Close: | $14.81 |
High: | $16.01 |
Low: | $14.005 |
Volume: | 216,501 |
Last Trade Date Time: | 04/22/2024 03:00:00 am |
News | Skye Bioscience Inc Com (OTCMKTS:SKYE)
SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye" or the "Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system...
2024-07-01 11:13:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s note: “Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’ “ was previously published in May 2024. It has since been updated...
Message Board Posts | Skye Bioscience Inc Com (OTCMKTS:SKYE)
Subject | By | Source | When |
---|---|---|---|
NEWS: Skye Bioscience Begins Dosing Phase 1 Fourth | lolroflmao | investorshub | 04/27/2023 11:55:45 AM |
News: Skye Bioscience Receives Positive Safety Review of | lolroflmao | investorshub | 04/04/2023 1:31:37 PM |
News: Skye Bioscience's Novel Cannabinoid Derivative Reduces Pain | lolroflmao | investorshub | 04/03/2023 1:02:54 PM |
Don't live for the approval of others. Only | WallStreetMyWay | investorshub | 03/16/2023 8:20:56 AM |
NEWS: Skye Bioscience Receives Human Research Ethics Committee Approval | lolroflmao | investorshub | 03/15/2023 12:39:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Skye Bioscience Inc Com Company Name:
SKYE Stock Symbol:
OTCMKTS Market:
Skye Bioscience Inc Com Website:
SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye" or the "Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system...
SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announ...